2[25]Chen Z,Zhang X,Li M,Wang Z,Wieand HS,Grandis JR,Shin DM.Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2,an efficient approach to inhibition of squamous cell carcinoma of the head and neck.Clin Cancer Res 2004; 10:5930-5939
3[26]Marnett LJ.Aspirin and the potential role of prostaglandins in colon cancer.Cancer Res 1992; 52:5575-5589
4[27]Hla T,Ristimaki A,Appleby S,Barriocanal JG.Cyclooxygenase gene expression in inflammation and angiogenesis.Ann N Y Acad Sci 1993; 696:197-204
5[28]Chung HY,Kim HJ,Kim JW,Yu BP.The inflammation hypothesis of aging:molecular modulation by calorie restriction.Ann N Y Acad Sci 2001; 928:327-335
7[30]Hanif R,Pittas A,Feng Y,Koutsos MI,Qiao L,Staiano-Coico L,Shiff SI,Rigas B.Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.Biochem Pharmacol 1996; 52:237-245
8[31]Goldberg Y,Nassif Ⅱ,Pittas A,Tsai LL,Dynlacht BD,Rigas B,Shiff SJ.The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells:alterations in tumor suppressor and cell cycle-regulatory proteins.Oncogene 1996; 12:893-901
9[32]Morham SG,Langenbach R,Loftin CD,Tiano HF,Vouloumanos N,Jennette JC,Mahler JF,Kluckman KD,Ledford A,Lee CA,Smithies O.Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.Cell 1995; 83:473-482
10[33]Ullrich A,Schlessinger J.Signal transduction by receptors with tyrosine kinase activity.Cell 1990; 61:203-212
